- Report
- June 2022
- 67 Pages
Australia
From €1963EUR$2,250USD£1,709GBP
- Report
- September 2024
- 170 Pages
Global
From €4357EUR$4,995USD£3,795GBP
- Report
- February 2024
- 244 Pages
Global
€4357EUR$4,995USD£3,795GBP
- Report
- February 2024
- 176 Pages
Global
€4357EUR$4,995USD£3,795GBP
- Report
- August 2024
- 187 Pages
Global
From €4357EUR$4,995USD£3,795GBP
- Report
- February 2024
- 326 Pages
Global
€4357EUR$4,995USD£3,795GBP
- Report
- September 2024
- 90 Pages
From €2573EUR$2,950USD£2,241GBP
- Report
- September 2024
- 175 Pages
Global
From €4318EUR$4,950USD£3,760GBP
- Report
- December 2025
- 150 Pages
Germany
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
Japan
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- November 2025
- 150 Pages
China
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- October 2025
- 150 Pages
China
From €3358EUR$3,850USD£2,925GBP
€4231EUR$4,850USD£3,684GBP
- Report
- April 2023
- 80 Pages
United Kingdom
From €1308EUR$1,500USD£1,140GBP
- Report
- April 2023
- 80 Pages
Russia
From €1308EUR$1,500USD£1,140GBP
- Report
- April 2023
- 80 Pages
Poland
From €1308EUR$1,500USD£1,140GBP
- Report
- April 2023
- 180 Pages
Global
From €1090EUR$1,250USD£950GBP
€2181EUR$2,500USD£1,899GBP
- Report
- January 2023
- 100 Pages
Global
From €1090EUR$1,250USD£950GBP
€2181EUR$2,500USD£1,899GBP
- Training
- 7 Hours
United States
From €1282EUR$1,470USD£1,117GBP
- Report
- November 2025
- 81 Pages
From €3009EUR$3,450USD£2,621GBP
- Report
- October 2025
- 87 Pages
Greece
From €4231EUR$4,850USD£3,684GBP

The Botanical Drug market is a subset of the Pharmaceutical industry, focusing on the development and commercialization of drugs derived from plants. Botanical drugs are typically derived from natural sources, such as herbs, roots, and other plant-based materials. These drugs are often used to treat a variety of conditions, including chronic pain, inflammation, and neurological disorders. Botanical drugs are typically administered orally, and may also be used in combination with other drugs.
The Botanical Drug market is highly regulated, with stringent safety and efficacy standards in place to ensure the safety of patients. Additionally, the market is subject to a variety of government regulations, including those related to the manufacturing and distribution of botanical drugs.
Some companies in the Botanical Drug market include PhytoCeutica, Inc., PhytoTech Therapeutics, and PhytoHealth Corporation. Show Less Read more